Traverso, I., Soncini, D., Giorgetti, G., Ravera, S., Ivanisevic, J., Garibotto, M., Gallo, M., Guolo, F., Cagnetta, A., Lemoli, R. and Cea, M. (2026) “P100 | Enhanced NAD⁺ biosynthesis and PPP activation drive venetoclax resistance in multiple myeloma: therapeutic reversal by NAMPT inhibition: I. Traverso1, D. Soncini1|2, G. Giorgetti2, S. Ravera3, J. Ivanisevic4, M. Garibotto2, M. Gallo1, F. Guolo1|2, A. Cagnetta2, R.M. Lemoli1|2, M. Cea1|2 | 1Clinic of Hematology, Department of Internal Medicine and Medical Specialties DiMI, University of Genoa; 2IRCCS Ospedale Policlinico San Martino; 3Department of Experimental Medicine DIMES, University of Genoa, Italy 4Metabolomics Unit, Faculty of Biology and Medicine, University of Lausanne, Switzerland.”, Haematologica. Pavia, Italy, 111(s1). doi: 10.3324/haematol.2026.s1.157.